Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended |
Mar. 31, 2018 | Mar. 31, 2017 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Total Operating Expenses | | $ 2,806,574 | | $ 2,502,819 | |
Compensation expense related to the company's stock-based compensation plans | | 35,500 | | 30,500 | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 12,000 | | $ 11,000 | |
Common Shares Available for Grant | | 16,800,000 | | | |
Stock Options and SARs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Unrecognized compensation expense | | $ 88,200 | | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 1 year 8 months 12 days | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | $ 28.19 | | $ 29.13 | |
Expected Volatility (in hundredths) | | 29.01% | | 31.67% | |
Risk-Free Interest Rate (in hundredths) | | 2.09% | | 1.36% | |
Dividend Yield (in hundredths) | | 0.66% | | 0.67% | |
Expected Life (in years) | | 5 years | | 5 years 3 months 18 days | |
Stock Options and SARs Rollforward [Abstract] | | | | | |
Outstanding at January 1 (in shares) | | 9,103,000 | | 9,850,000 | |
Granted (in shares) | | 16,000 | | 5,000 | |
Exercised (1) (in shares) | [1] | (752,000) | | (600,000) | |
Forfeited (in shares) | | (77,000) | | (99,000) | |
Outstanding at March 31 (2) (in shares) | [2] | 8,290,000 | | 9,156,000 | |
Stock Options and SARs Vested or Expected to Vest (in shares) | [3] | 7,940,000 | | 8,849,000 | |
Stock Options and SARs Exercisable at September 30 (in shares) | [4] | 3,803,000 | | 5,078,000 | |
Intrinsic Value of Stock Options/SARs Exercised | | $ 28,400 | | $ 26,600 | |
Intrinsic Value of Stock Options/SARs Outstanding | | $ 170,700 | | $ 199,300 | |
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding | | 4 years 3 months 18 days | | 3 years 9 months 18 days | |
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest | | $ 166,100 | | $ 196,000 | |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)al Term | | 4 years 2 months 12 days | | 3 years 9 months 18 days | |
Aggregate Intrinsic Value for Exercisable Units | | $ 110,800 | | $ 155,500 | |
Weighted average remaining contractual life for exercisable options/SARs (in years) | | 2 years 7 months 6 days | | 2 years 4 months 24 days | |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | | |
Outstanding at January 1 (price per share) | | $ 83.89 | | $ 75.53 | |
Granted (price per share) | | 106.76 | | 101.61 | |
Exercised (1) (price per share) | [1] | 74.65 | | 57.53 | |
Forfeited (price per share) | | 91.94 | | 88.57 | |
Outstanding at March 31 (2) (price per share) | [2] | 84.7 | | 76.59 | |
Vested or Expected to Vest (3) (price per share) | [3] | 84.38 | | 76.20 | |
Exercisable at March 31 (4) (price per share) | [4] | 76.16 | | 67.74 | |
ESPP [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | $ 23.27 | | $ 24.28 | |
Expected Volatility (in hundredths) | | 22.04% | | 30.33% | |
Risk-Free Interest Rate (in hundredths) | | 1.60% | | 0.65% | |
Dividend Yield (in hundredths) | | 0.66% | | 0.69% | |
Expected Life (in years) | | 6 months | | 6 months | |
Restricted Stock And Restricted Stock Units [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Unrecognized compensation expense | | $ 172,700 | | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 2 years 4 months 24 days | | | |
Intrinsic value released during the year | | $ 28,400 | | $ 36,000 | |
Aggregate intrinsic value of stock and units outstanding | | 403,500 | | 382,600 | |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 22,400 | | $ 18,600 | |
Outstanding at January 1 (in shares) | | 3,905,000 | | 3,962,000 | |
Granted (in shares) | | 279,000 | | 402,000 | |
Released (1) (in shares) | [5] | (276,000) | | (360,000) | |
Forfeited (in shares) | | (75,000) | | (82,000) | |
Outstanding at March 31 (2) (in shares) | [6] | 3,833,000 | | 3,922,000 | |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | $ 88.57 | | $ 79.63 | |
Granted (price per share) | | 102.27 | | 99.52 | |
Released (1) (price per share) | [5] | 66.46 | | 61.96 | |
Forfeited (price per share) | | 90.65 | | 82.83 | |
Outstanding at March 31 (2) (price per share) | [6] | $ 91.12 | | $ 83.22 | |
Performance Units and Performance Stock [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 1,100 | | $ 900 | |
Unrecognized compensation expense | | $ 7,200 | | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | 1 year 9 months 18 days | | | |
Intrinsic value released during the year | | $ 9,000 | | | |
Aggregate intrinsic value of stock and units outstanding | | $ 60,400 | | $ 56,100 | |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | 502,331 | | 545,290 | |
Granted (in shares) | | 0 | | 0 | |
Granted for Performance Multiple (1) | [7] | 71,805 | | 118,834 | |
Released (1) (in shares) | | 0 | | 89,224 | [8] |
Forfeited (in shares) | | 0 | | 0 | |
Outstanding at March 31 (2) (in shares) | [9] | 574,136 | [10] | 574,900 | |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | $ 90.96 | | $ 80.92 | |
Granted (price per share) | | 0 | | 0 | |
Granted for Performance Multiple (1) (in dollars per share) | [7] | 101.87 | | 84.43 | |
Released (1) (price per share) | [8] | 0 | | 84.43 | |
Forfeited (price per share) | | 0 | | 0 | |
Outstanding at March 31 (2) (price per share) | [9] | $ 92.33 | | $ 81.10 | |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | |
Performance Period for Performance Units and Shares | | 3 years | | | |
Minimum Performance Multiple at the Completion of the Performance Period | | 0.00% | | | |
Maximum Performance Multiple at the Completion of the Performance Period | | 200.00% | | | |
Minimum Performance Units and Stock Allowed to be Outstanding | | 292,054 | | | |
Maximum Performance Units and Stock Allowed to be Outstanding | | 856,218 | | | |
Lease And Well [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 12,800 | | $ 10,900 | |
Gathering And Processing Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 100 | | 200 | |
Exploration Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 6,900 | | 6,200 | |
General And Administrative [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 15,700 | | $ 13,200 | |
| |
[1] | The total intrinsic value of stock options/SARs exercised for the three months ended March 31, 2018 and 2017 was $28.4 million and $26.6 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at March 31, 2018 and 2017 was $170.7 million and $199.3 million, respectively. At March 31, 2018 and 2017, the weighted average remaining contractual life was 4.3 years and 3.8 years, respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2018 and 2017 was $166.1 million and $196.0 million, respectively. At March 31, 2018 and 2017, the weighted average remaining contractual life was 4.2 years and 3.8 years, respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at March 31, 2018 and 2017 was $110.8 million and $155.5 million, respectively. At March 31, 2018 and 2017, the weighted average remaining contractual life was 2.6 years and 2.4 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released for the three months ended March 31, 2018 and 2017 was $28.4 million and $36.0 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2018 and 2017 was $403.5 million and $382.6 million, respectively. | |
[7] | Upon completion of the Performance Period for the Performance Awards granted in 2014 and 2013, a performance multiple of 200% was applied to each of the grants resulting in additional grants of Performance Awards in February 2018 and February 2017, respectively. | |
[8] | The total intrinsic value of Performance Awards released during the three months ended March 31, 2017 was approximately $9 million. | |
[9] | The total intrinsic value of Performance Awards outstanding at March 31, 2018 and 2017 was approximately $60.4 million and $56.1 million, respectively. | |
[10] | Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 292,054 and a maximum of 856,218 Performance Awards could be outstanding. The intrinsic value is based upon the closing price of EOG's common stock on the date Performance Awards are released. | |